BioCardia, Inc. (BCDA) — 分析师展望 / 分析师共识目标价为. 基于 5 位分析师评级, 共识为 看涨 — 4 买入, 1 持有.
分析师预估 每股收益(EPS)为 $-3.11 和 营收为 $0.00B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-2.90 vs 预期 $-3.11 (超预期 +6.8%). 2025: 实际 $-1.23 vs 预期 $-1.20 (不及预期 -2.5%). 分析师准确度: 95%.
BCDA 分析师评级
Buy
基于过去3个月内 5 位分析师对 BioCardia, Inc. 的评级
EPS 预测 — BCDA
95%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$2.90
vs Est –$3.11
▲ 7.2% off
2025
Actual –$1.23
vs Est –$1.20
▼ 2.4% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
营收预测 — BCDA
42%
Analyst Accuracy
Inaccurate
1 year compared
Actual vs Estimate
2024
Actual $0.000B
vs Est $0.000B
▼ 57.8% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
